Stock report · Delisted · Nasdaq
GlycoMimetics Inc (GLYC)
0.16USD Delisted Final close · Jun 13, 2025
GLYC no longer trades. GlycoMimetics was delisted from the Nasdaq in June 2025.
All prices on this page are historical. The last trade was on June 13, 2025, at $0.16.
GLYC stock price history
Final trading statistics
- Final close
- $0.16
- Final trading day
- Jun 13, 2025
- Market cap at delisting
- $10.13M
- Shares outstanding
- 64.53M
- Final 52-week range
- $0.14 – $18.40
- Avg. volume (final 3 mo.)
- 1,726,386
- All-time high
- $25.35 · Feb 2018
- All-time low
- $0.14 · Oct 2024
- Return since IPO
- -98.3%
- Beta
- 1.60
- Book value / share
- $5.23
- Price / book
- 0.03
About GlycoMimetics Inc
GlycoMimetics was a U.S. company that discovered and developed therapies for cancer and inflammatory diseases. It was founded in 2003 and based in Monrovia, Maryland. Its shares were delisted from the Nasdaq in June 2025, with the last trade on June 13, 2025 at $0.16.
- Exchange (former)
- Nasdaq
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Monrovia, MD
- Employees
- 4
- IPO date
- January 10, 2014
- Delisted
- June 13, 2025
- SEC CIK
- 1253689
GlycoMimetics financials before the delisting
The last 5 fiscal years GlycoMimetics reported as a public company, fiscal year ending December.
GLYC revenue and net income
GLYC earnings per share
GLYC annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2024 | $0.00 | −$37.9M | −$0.59 |
| FY2023 | $10.0K | −$36.9M | −$0.58 |
| FY2022 | $74.9K | −$93.3M | −$0.88 |
| FY2021 | $1.16M | −$63.1M | −$1.23 |
| FY2020 | $10.16M | −$50.3M | −$1.11 |
Net income is GAAP. EPS is adjusted (non-GAAP) EPS, as reported.
GlycoMimetics stock FAQ
What happened to GlycoMimetics stock?
GlycoMimetics was delisted from the Nasdaq in June 2025. The final close was $0.16 on June 13, 2025.
Can I still buy GLYC stock?
No. GLYC is no longer listed on the Nasdaq or any other U.S. exchange; it was removed on June 13, 2025.
What was the last price of GLYC?
GLYC last closed at $0.16 on June 13, 2025, which valued the company at about $10.13M.
How did GlycoMimetics do in its last full fiscal year?
In fiscal 2024, its last full year as a public company, GlycoMimetics reported revenue of $0.00 and net income of −$37.9M.
When did GlycoMimetics go public?
GlycoMimetics shares started trading on January 10, 2014.
GLYC no longer trades, so there is no live quote. The information on this page is for reference only and is not investment advice; see our disclaimer.